⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEVA News
Teva Pharmaceutical Industries Limited American Depositary Shares
Molecular Switch Targeting Therapies Market Research Report 2026: Opportunities in Targeted Drug Delivery Systems and Therapies in Oncology, Autoimmune, Inflammatory, and Neurological Disorders
globenewswire.com
MRK
BMY
AZN
PFE
NVS
LLY
GILD
JNJ
REGN
ABBV
NVO
SNY
VRTX
AMGN
BIIB
INCY
EXEL
SRPT
CRSP
EDIT
NTLA
ALNY
MRNA
BNTX
COHR
IMUX
INSM
CYTK
KODK
LULU
NVDA
GOOG
MSFT
IBM
AMAT
ILMN
ALKS
ACAD
MNKD
TEVA
BHC
XBI
IBB
XLF
XLK
XLV
JAZZ
ACGL
XBOW任命WonLae Lee為韓國區總經理
businesswire.com
GOOG
MSFT
AMZN
META
NVDA
IBM
ORCL
CSCO
ADBE
CRM
INTC
AMD
QCOM
MU
AMAT
LRCX
KLAC
TXN
ADI
NXPI
ON
MPWR
AEHR
TER
ASML
AMGN
GILD
BIIB
REGN
VRTX
BMY
PFE
MRK
JNJ
ABBV
LLY
XOM
CVX
SHEL
BABA
JD
NTES
PDD
VIPS
HTHT
BEKE
EDU
RLX
LI
XPEV
NIO
CPT
TCOM
RBLX
TTD
MELI
PYPL
COIN
HOOD
UPST
SOFI
AFRM
PLTR
SNOW
DDOG
CRWD
PANW
FTNT
OKTA
CHKP
FFIV
HPQ
DELL
HPE
ACN
CGC
ACB
TLRY
CRON
OGI
SPCE
RKLB
ASTS
PLD
AMT
EQIX
CCI
SBAC
TMUS
VZ
EA
TTWO
U
CRSP
EDIT
NTLA
AZN
BNTX
MRNA
TMO
DHR
GOOGL
AAPL
TSLA
NFLX
DIS
CMCSA
PEP
KO
MCD
WMT
COST
TGT
HD
LOW
CHTR
T
SBUX
NKE
MGM
LVS
WYNN
CCL
RCL
NCLH
AAL
UAL
DAL
LUV
BA
GD
LMT
RTX
NOC
HON
GE
MMM
CAT
DE
AGCO
CNH
IR
SNA
TT
ETN
ROK
EMR
AXP
V
MA
BAC
JPM
WFC
C
GS
MS
SCHW
USB
PNC
BBT
STI
KEY
FITB
HBAN
RF
ZION
AXSM
ALKS
TEVA
BMRN
IDXX
EL
LULU
CPRI
PVH
RL
KSS
BBY
DLTR
DG
TJX
ROST
ULTA
MDT
SYK
ISRG
EW
ABT
BSX
XRAY
CTAS
PAYX
ADP
FIS
FISV
Medincell : Information relative au nombre d’actions composant le capital social et au nombre total des droits de vote
businesswire.com
TEVA
Medincell: Half-year Liquidity Contract Statement
businesswire.com
TEVA
Medincell : Bilan semestriel du contrat de liquidité
businesswire.com
TEVA
Marquis Who's Who Honors David Grote for Leadership in Pharmaceutical Quality Assurance
accessnewswire.com
AMGN
TEVA
GSK
Buprenorphine Patches Market Forecast Intelligence Report 2026-2032: Global, Regional and Country-Level Coverage
globenewswire.com
AMRX
VRTS
TEVA
LPCN
SUN
Topiramate Drugs Market - Global and Regional Trends, Drivers, and Growth Forecast 2026-2032 with Competition and Value Chain Analysis
globenewswire.com
AMRX
JNJ
TEVA
House Dust Mite Disease Market to Exhibit Substantial Growth at a CAGR of 3.5% During the Forecast Period (2025-2034) | DelveInsight USA - English USA - English
prnewswire.com
ALKS
STG
GSK
SNY
TEVA
AZN
INCY
REGN
PFE
BMY
LLY
AMGN
ABBV
GILD
BIIB
CSL
VRTX
BHC
NVS
MRK
LEO
ALLT
CNTB
INM
AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine
globenewswire.com
TEVA